An interventional study of personalized preventive health information and non-personalized preventive health information in Prevention, sponsored by Centre Hospitalier le Mans. Not yet recruiting at 2 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-22.
Sponsored by Centre Hospitalier le Mans · Not applicable, Interventional, and Prevention
Prevention, a cornerstone of public health, remains underutilized despite its proven effectiveness. Vaccinations, screenings, reduced consumption of toxic substances, and healthy lifestyle and dietary habits can significantly reduce morbidity and mortality. However, participation rates in France remain low compared to those of neighboring European countries, particularly with regard to cancer screenings and vaccination coverage. A lack of information, motivation, or unequal access hinders adherence to preventive measures. Some of these factors can be addressed.
Emergency departments, although rarely utilized for prevention, serve a diverse population and could serve as a strategic lever for educating the public about preventive health measures.
Personalized information, supported by a digital tool, could improve adherence to preventive measures. An interactive questionnaire was developed to tailor the information provided to patients based on their personal characteristics. The information delivered in this way would be more targeted for each patient and more likely to have a positive impact on the implementation of various preventive measures.
The purpose of this study is to determine whether a digital tool that provides personalized prevention information is more effective than general, non-personalized information in improving adherence among patients visiting the emergency department to the preventive measures recommended for them.
Exclusion Criteria:
The first "intervention" group, designated A, is exposed to personalized information via a digital educational tool based on the characteristics entered for them.
Procedure: personalized preventive health information
The second "control" group, designated B, receives non-personalized information. Using the same digital tool, the patient receives all the preventive health information without it being tailored to the patient. The patient therefore does not see any information specific to him or her.
Procedure: non-personalized preventive health information
The intervention involves providing personalized preventive health information regarding recommended preventive measures based on age, biological sex, weight, height, bedtime and wake-up times, the presence of chronic conditions, and tobacco or alcohol use.
The intervention involves providing non-personalized preventive health information. The patient receives all the preventive health information without it being tailored to the patient. The patient therefore does not see any information specific to him or her.
proportion of patients who adhered to at least 25% of the preventive measures
The primary outcome measure is the proportion of patients who adhered to at least 25% of the preventive measures for which they were eligible, as assessed 6-8 weeks after the intervention. Adherence is defined as the completion of a preventive measure or the initiation of steps leading to its completion in the short term
Time frame: 6-8 weeks after the intervention.
The proportion of patients who adhered to each of the preventive measures studied.
Time frame: 6-8 weeks after the intervention.
The proportion of preventive measures taken by the patient, relative to the measures for which the patient is eligible.
Time frame: 6-8 weeks after the intervention.
The enrollment rate for each epidemiological subgroup (age, sex, whether the patient has a primary care physician, whether the patient has a chronic condition, socioeconomic status).
Time frame: 6-8 weeks after the intervention.
This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier le Mans